We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Destiny Pharma Plc | LSE:DEST | London | Ordinary Share | GB00BDHSP575 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.00 | 2.50 | 3.50 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 13/8/2024 | 06:00 | UK RNS | AIM Cancellation - Destiny Pharma plc |
| 12/8/2024 | 06:00 | UK RNS | Destiny Pharma PLC Last Day of Dealings on AIM |
| 05/8/2024 | 10:58 | UK RNS | Destiny Pharma PLC Director/PDMR Shareholding |
| 05/8/2024 | 08:50 | ALNC |  Destiny Pharma shares fall amid XF-73 fending off MRSA in wounds |
| 05/8/2024 | 06:00 | UK RNS | Destiny Pharma PLC XF-73 prevents bacterial invasion of bloodstream |
| 31/7/2024 | 10:00 | UK RNS | Destiny Pharma PLC Result of GM and Cancellation of Trading on AIM |
| 22/7/2024 | 06:00 | UK RNS | Destiny Pharma PLC Treatment of XF-73 Nasal reduces antibiotic use |
| 15/7/2024 | 08:25 | ALNC | Destiny Pharma looks to go private to raise funds, avoid liquidation |
| 15/7/2024 | 06:00 | UK RNS | Destiny Pharma PLC Proposed Cancellation of Admission to Trading |
| 20/6/2024 | 06:00 | UK RNS | Destiny Pharma PLC Exercise of Options and Total Voting Rights |
1 Year Destiny Pharma Chart |
Intraday Destiny Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
